Immune pathogenesis of hepatocellular carcinoma

被引:281
|
作者
Nakamoto, Y [1 ]
Guidotti, LG [1 ]
Kuhlen, CV [1 ]
Fowler, P [1 ]
Chisari, FV [1 ]
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, Div Expt Pathol, La Jolla, CA 92037 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1998年 / 188卷 / 02期
关键词
cytotoxic T lymphocytes; hepatitis B virus; chronic hepatitis; hepatocellular carcinoma; transgenic mice;
D O I
10.1084/jem.188.2.341
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatocellular carcinoma (HCC) is a common complication of chronic hepatitis B virus (HBV) infection. The pathogenetic mechanisms potentially responsible for HCC during chronic HBV infection are not well defined. This study demonstrates that chronic immune-mediated liver cell injury triggers the development of HCC in the absence of viral transactivation, insertional mutagenesis, and genotoxic chemicals. These results strongly suggest that the immune response to HBV is both necessary and sufficient to cause liver cancer during chronic HBV infection, and that all other procarcinogenic events associated with HCC are probably dependent on this process.
引用
收藏
页码:341 / 350
页数:10
相关论文
共 50 条
  • [31] Molecular pathogenesis of human hepatocellular carcinoma
    Wang, XW
    Hussain, SP
    Huo, T
    Wu, CG
    Forgues, M
    Hofseth, LJ
    Brechot, C
    Harris, CC
    TOXICOLOGY, 2001, 164 (1-3) : 5 - 5
  • [32] Pathogenesis of hepatocellular carcinoma according to aetiology
    Nault, Jean-Charles
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2014, 28 (05) : 937 - 947
  • [33] Molecular pathogenesis of human hepatocellular carcinoma
    Kern, MA
    Breuhahn, K
    Schirmacher, P
    ADVANCES IN CANCER RESEARCH, VOL 86, 2002, 86 : 67 - 112
  • [34] Immune Responses in Hepatocellular Carcinoma
    Korangy, Firouzeh
    Hoechst, Bastian
    Manns, Michael P.
    Greten, Tim F.
    DIGESTIVE DISEASES, 2010, 28 (01) : 150 - 154
  • [35] Immune therapy for hepatocellular carcinoma
    Yaron Ilan
    Hepatology International, 2014, 8 : 499 - 504
  • [36] Immune therapy for hepatocellular carcinoma
    Ilan, Yaron
    HEPATOLOGY INTERNATIONAL, 2014, 8 : S499 - S504
  • [37] Exosomes in Pathogenesis, Diagnosis, and Treatment of Hepatocellular Carcinoma
    Li, Shuang
    Chen, Limin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] PPAR Could Contribute to the Pathogenesis of Hepatocellular Carcinoma
    Kimura, Osamu
    Kondo, Yasuteru
    Shimosegawa, Tooru
    PPAR RESEARCH, 2012, 2012
  • [39] Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
    Asmaa Ibrahim Gomaa
    Shahid A Khan
    Mireille B Toledano
    Imam Waked
    Simon D Taylor- Robinson
    World Journal of Gastroenterology, 2008, (27) : 4300 - 4308
  • [40] Role of Immunity in Pathogenesis and Treatment of Hepatocellular Carcinoma
    Schmidt, Nathalie
    Thimme, Robert
    DIGESTIVE DISEASES, 2016, 34 (04) : 429 - 437